Results 71 to 80 of about 4,177 (192)

Botulinum Toxin A to sialorrhea treatment: a systematic review

, 2013
Objetivo: Sistematizar as evidências científicas sobre a eficácia da toxina botulínica tipo A no tratamento da sialorréia. Método: A busca bibliográfica foi realizada através de uma pesquisa nas bases de dados PubMed Central Journals e Allergan Product ...
Sposito, Maria Matilde de Mello, Teixeira, Stephanie Alderete Feres   +1 more
core   +1 more source

Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials

, 2023
Antipsychotic-induced sialorrhea carries a significant burden, but evidence-based treatment guidance is incomplete, warranting network meta-analysis (NMA) of pharmacological interventions for antipsychotic-related sialorrhea.
Billeci M., Pigato G., de Bartolomeis A., Solmi M., Lussignoli M., Shorr R., Caiolo S., Caiazza C., Solini N., Siskind D., De Prisco M., Barone A., Correll C. U., Vannini M., Fornaro M., Sambataro F., Claudio Caiazza, Andrea de Bartolomeis, Risa Shorr, Marco Solmi, Marialaura Lussignoli, Martina Vannini, Annarita Barone, Christoph U Correll, Michele Fornaro, Dan Siskind, Fabio Sambataro, Giorgio Pigato, Michele De Prisco, Niccolò Solini, Martina Billeci, Stefano Caiolo   +31 more
core   +1 more source

Combined management of spasticity and sialorrhea in children with cerebral palsy: a Russian multicenter retrospective study

Неврология, нейропсихиатрия, психосоматика
The use of botulinum toxin therapy to correct spasticity and sialorrhea in a single injection session is an adequate treatment strategy for children with cerebral palsy (CP), as these two conditions are often observed simultaneously in patients and ...
A. L. Kurenkov, D. A. Krasavina, E. A. Moroshek, T. A. Belogorova, V. V. Chernikov, A. R. Artemenko, A. V. Knyazev, M. M. Geraskina, B. I. Bursagova, L. M. Kuzenkova, E. V. Vinogradova, A. A. Balbert, V. I. Mikhnovich   +12 more
doaj   +1 more source

Sialorrhea in Patients with Parkinson's Disease: Safety and Administration of Botulinum Neurotoxin

Journal of Parkinson’s Disease, 2014
Sialorrhea may present as a troublesome symptom in patients suffering from Parkinson's disease. Current options for treatment include anticholinergic drugs, irradiation, surgery, oral-motor and behavioural therapies, and injection of botulinum neurotoxin
Gustav Egevad, Valentina Yankova Petkova, Ole Jakob Vilholm   +2 more
doaj   +1 more source

Hyperemesis gravidarum and oral health: A scoping review

International Journal of Gynecology &Obstetrics, Volume 175, Issue 1, Page 48-55, October 2026.
Abstract Background Hyperemesis gravidarum (HG) is a severe form of nausea and vomiting in pregnancy (NVP), associated with dehydration, nutritional deficiencies, and systemic complications. Although recurrent vomiting, altered dietary patterns, and medication effects might plausibly affect oral health, this relationship has not been comprehensively ...
Niamh Coffey, Lucy James, Angela C. Flynn, Zeinab El‐Dirani, Shahnawaz Khijmatgar   +4 more
wiley   +1 more source

A review of options for treating sialorrhea in amyotrophic lateral sclerosis

, 2015
Sialorrhea or drooling represents quite a common problem in patients with amyotrophic lateral sclerosis (ALS). In this review, we describe the possible treatments for this issue.
A. Lax, P. Banfi, G. A. Guidugli, A. Nicolini, N. Ticozzi, V. Silani   +5 more
core   +1 more source

Use of botulinum toxin in patients with dysphagia and sialorrhea in acute ischemic stroke

Неврология, нейропсихиатрия, психосоматика
Dysphagia and sialorrhea are common complications of stroke that worsen quality of life and increase the risk of aspiration pneumonia. Botulinum toxin type A (BoNT-A) injections are effective in the treatment of sialorrhea, but there are few data on the ...
V. V. Gusev, T. V. Balueva, O. V. Zayceva, D. A. Smirnov   +3 more
doaj   +1 more source

Botulinum toxin use in patients with neurological disorders: A U.S.‐based claims database analysis

PM&R, Volume 18, Issue 10, Page 1164-1175, October 2026.
Abstract Background and Objective Real‐world evidence describing long‐term persistency with botulinum toxin (BoNT) therapy is limited. We assessed treatment patterns and persistency with BoNT in clinical practice over 2 years. Design Retrospective, longitudinal, claims database analysis. Setting Medical claims data from the Merative MarketScan database
David M. Simpson, Jonathan Bouchard, Simon Page, Seth Goldfarb, Atul T. Patel   +4 more
wiley   +1 more source

eMethods supplement for Neurology publication "SIPEXI: Placebo-controlled clinical trial of incobotulinumtoxinA for sialorrhea in children"

, 2021
eMethods supplement for Neurology publication "SIPEXI: Placebo-controlled clinical trial of incobotulinumtoxinA for sialorrhea in children" by Berweck et al (published 2021). File provides methodological details (study design and statistics)
Mueller, Daniela, Althaus, Michael, Berweck, Steffen, Kim, Heakyung, Bonikowski, Marcin, Flatau-Baqué, Birgit, Banach, Marta   +6 more
core   +1 more source

Botulinum toxin in treatment of bruxism and sialorrhea: A bibliography revision

, 2023
Las técnicas con toxina botulínica tipo A (BT-A) representan la mejora de calidad de vida en pacientes con bruxismo y sialorrea. Nuestro objetivo es evaluar la eficacia del tratamiento con BT-A en estas patologías.
Oliveira García, Paloma
core   +1 more source